10YR企业会员
英文名称 | 中文名称 | CAS |
---|---|---|
VX702 | 6-[(氨基羰基)(2,6-二氟苯基)氨基]-2-(2,4-二氟苯基)-3-吡啶甲酰胺 | 745833-23-2 |
RaMipril | 雷米普利 | 87333-19-5 |
Danoprevir (ITMN-191;RG7227) | 丹诺普韦 | 850876-88-9 |
SAR407899 | 6-(哌啶-4-氧基)异喹啉-1(2H)-酮盐酸盐 | 923262-96-8 |
PF-06463922 | 劳拉替尼 | 1454846-35-5 |
LDC1267 | LDC1267 | 1361030-48-9 |
EPZ015666 | EPZ015666 | 1616391-65-1 |
Zanamivir | 扎那米韦一水合物 | 139110-80-8 |
Ilomastat (GM6001, Galardin) | 伊洛马司他 | 142880-36-2 |
LY294002 | LY294002/PI3K抑制剂 | 154447-36-6 |
Fedratinib (SAR302503, TG101348) | N-(1,1-二甲基乙基)-3-[[5-甲基-2-[[4-[2-(1-吡咯烷基)乙氧基]苯基]氨基]-4-嘧啶基]氨基]苯磺酰胺 | 936091-26-8 |
ABT-492;Delafloxacin | 德拉沙星API | 189279-58-1 |
LY 2874455 | LY2874455 | 1254473-64-7 |
STF-31 | 4-((4-(叔丁基)苯基磺酰胺基)甲基)-N-(吡啶-3-基)苯甲酰胺 | 724741-75-7 |
ML-323 | ML323 | 1572414-83-5 |
Oltipraz | 吡噻硫酮 | 64224-21-1 |
SANT-1 | SANT1 | 304909-07-7 |
Otenabant (CP-945598) HCl | CP945598 | 686347-12-6 |
BMS-582949 | BMS 582949 | 623152-17-0 |
Poziotinib (HM781-36B) | 波齐替尼 | 1092364-38-9 |
Citarinostat (ACY-241) | 西他司他 | 1316215-12-9 |
Pexidartinib (PLX3397) | 培西达替尼 | 1029044-16-3 |
Davercin | 环酯红霉素 | 55224-05-0 |
Endoxifen | (Z)-N-去甲基-4-羟基三苯氧胺 | 112093-28-4 |
Cobimetinib (GDC-0973, RG7420) | 考比替尼 | 934660-93-2 |
TG-02/SB-1317 | 14-甲基-20-氧杂-5,7,14,27-四氮杂四环[19.3.1.1(2,6).1(8,12)]二十七碳-1(25),2,4,6(27),8,10,12(26),16,21,23-十烯 | 937270-47-8 |
SAR131675 | SAR131675 | 1092539-44-0 |
Radotinib(IY-5511) | 拉多替尼 | 926037-48-1 |
AG-120 (Ivosidenib) | 艾伏尼布 | 1448347-49-6 |
SQ 22,536 | 9-(四氢-2-呋喃)腺膘呤 | 17318-31-9 |
GDC0853 | GDC-0853 | 1434048-34-6 |
AN2728 | 克立硼罗 | 906673-24-3 |
Pristinamycin | 普那霉素 | 270076-60-3 |
GSK 525762A | (4S)-6-(4-氯苯基)-N-乙基-8-甲氧基-1-甲基-4H-[1,2,4]三唑并[4,3-A][1,4]苯并二氮杂卓-4-乙酰胺 | 1260907-17-2 |
TAK-385 | 瑞卢戈利 | 737789-87-6 |
LDE-225 Diphosphate | SONIDEGIB PHOSPHATE | 1218778-77-8 |
SAR405838 (MI-773) | SAR 405838 | 1303607-60-4 |
LY2409881 | IKK2抑制剂(LY2409881) | 946518-60-1 |
AZD3839 | AZD3839 | 1227163-84-9 |
PFK-158 | 1G,10G,100G,1KG | 1462249-75-7 |
Eliprodil | 依利罗地 | 119431-25-3 |
ITSA-1 | 1-(2,4-DICHLOROBENZOYL)-1H-BENZOTRIAZOLE | 200626-61-5 |
T0070907 | T0070907 | 313516-66-4 |
Tacrolimus(FK-506) | 他克莫司一水合物 | 109581-93-3 |
Efaproxiral sodium | 乙丙昔罗钠 | 170787-99-2 |
SNS-032 (BMS-387032)? | SNS-032 | 345627-80-7 |
LX-4211; Sotagliflozin | 索格列净 | 1018899-04-1 |
Refametinib | 瑞法替尼 | 923032-37-5 |
PF-8380 | 4-[3-氧代-3-(2-氧代-2,3-二氢苯并恶唑-6-基)丙基]哌嗪-1-羧酸 3,5-二氯苄酯 | 1144035-53-9 |
K03861 | K03861 | 853299-07-7 |
FPS-ZM1 | N-BENZYL-4-CHLORO-N-CYCLOHEXYLBENZAMIDE | 945714-67-0 |
RGB-286638 | N-[1,4-二氢-3-[4-[[4-(2-甲氧基乙基)-1-哌嗪基]甲基]苯基]-4-氧代茚并[1,2-C]吡唑-5-基]-N'-4-吗啉基脲 | 784210-88-4 |
LY-2584702 tosylate salt | LY2584702 TOSYLATE | 1082949-68-5 |
Dalcetrapib(JTT 705) | CETP抑制剂 | 211513-37-0 |
Enasidenib | 恩西地平 | 1446502-11-9 |
blu554 | BLU554 | 1707289-21-1 |
ONO-7300243 | 638132-34-0 | 638132-34-0 |
Anisomycin | 茴香霉素 | 22862-76-6 |
PD153035 HCl | PD153035 HCl | 183322-45-4 |
Saracatinib | 塞卡替尼 | 379231-04-6 |
WZ 811 | WZ 811 | 55778-02-4 |
FH535 | 2,5-二氯-N-(2-甲基-4-硝基苯基)苯磺酰胺 | 108409-83-2 |
E-3810(Lucitanib) | 德立替尼 | 1058137-23-7 |
Wnt-C59 | PORCN酶活性和WNT抑制剂(WNT-C59) | 1243243-89-1 |
TAK-063 | 1-(2-氟-4-(1H-吡唑-1-基)苯基)-5-甲氧基-3-(1-苯基-1H-吡唑-5-基)哒嗪-4(1H)-酮 | 1238697-26-1 |
ARQ-092 | ARQ-092 | 1313881-70-7 |
Trifluridine | 三氟胸苷 | 70-00-8 |
GW9508 | 885101-89-3(GW9508) | 885101-89-3 |
Linagliptin | 利拉列汀 | 668270-12-0 |
AZD7762 | 3-[(氨基羰基)氨基]-5-(3-氟苯基)-N-(3S)-3-哌啶基-2-噻吩羧胺 | 860352-01-8 |
Tepotinib(EMD 1214063) | 特泊替尼 | 1100598-32-0 |
Edoxaban tosylate | 依度沙班对甲苯磺酸盐 | 480449-71-6 |
GSK126 | GSK126 | 1346574-57-9 |
ABT-450 | 帕利瑞韦 | 1221573-85-8 |
GNE-9605 | GNE-9605 | 1536200-31-3 |
Molidustat(BAY 85-3934) | MOLIDUSTAT | 1154028-82-6 |
Tazarotene | 他扎罗汀 | 118292-40-3 |
Vinblastine sulfate | 硫酸长春碱 | 143-67-9 |
SKF 96365 HCI | 1-[2-(4-甲氧基)-2-[3-(4-甲氧基苯基)丙氧基]乙基]咪唑 | 130495-35-1 |
SD-208 | SD-208 | 627536-09-8 |
IRAK-1-4 Inhibitor I | IRAK-1-4 抑制剂 I | 509093-47-4 |
XAV-939 | 3,5,7,8-四氢-2-[4-(三氟甲基)苯基]-4H-噻喃并[4,3-D]嘧啶-4-酮 | 284028-89-3 |
LY 2228820 | 5-[2-(叔丁基)-4-(4-氟苯基)-1H-咪唑-5-基]-3-(2,2-二甲基丙基)-3H-咪唑并[4,5-B]吡啶-2-胺甲磺酸盐 | 862507-23-1 |
WP1066 | (2E)-3-(6-溴-2-吡啶基)-2-氰基-N-[(1S)-1-苯基乙基]-2-丙烯酰胺 | 857064-38-1 |
BAY 1000394 (Roniciclib) | BAY1000394 | 1223498-69-8 |
RO5126766(CH5126766) | RO5126766(CH5126766) | 946128-88-7 |
BMH-21 | BMH-21 | 896705-16-1 |
BRD73954 | BRD73954 | 1440209-96-0 |
SR 12813 | (2-(3,5-二叔丁基-4-羟基苯基)乙烯-1,1-二基)双(膦酸)四乙酯 | 126411-39-0 |
SAG.HCI | SAG | 912545-86-9 |
MI-2 (MALT1 inhibitor) | 2-氯-N-[4-[5-(3,4-二氯苯基)-3-(2-甲氧基乙氧基)-1H-1,2,4-三唑-1-基]苯基]乙酰胺 | 1047953-91-2 |
Oritavancin | 奥利万星 | 171099-57-3 |
RO-3306 | 2-[[(噻吩-2-基)甲基]氨基]-5-[1-(喹啉-6-基)甲-(Z)-亚基]噻唑-4-酮 | 872573-93-8 |
GS-7340 | 泰诺福韦艾拉酚胺 | 379270-37-8 |
ZM 323881 Hydrochloride | 5-[(7-苄氧基喹唑啉-4-基)氨基]-4-氟-2-甲基苯酚盐酸盐 | 193000-39-4 |
Altiratinib(DCC2701) | ALTIRATINIB | 1345847-93-9 |
AZD6738 | AZD6738 | 1352226-88-0 |
UNC3866 | UNC3866 | 1872382-47-2 |
Ro 48-8071 fumarate | 富马酸盐 | 189197-69-1 |
Nebivolol hydrochloride | 盐酸奈必洛尔 | 152520-56-4 |
联系方式